Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells.
about
Antineoplastic effects of CPPTL via the ROS/JNK pathway in acute myeloid leukemia.GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to ChemotherapyApoptosis induction by alantolactone in breast cancer MDA-MB-231 cells through reactive oxygen species-mediated mitochondrion-dependent pathway.Anticancer Activity of Curcumin-Loaded PLGA Nanoparticles on PC3 Prostate Cancer Cells.Alantolactone, a sesquiterpene lactone, inhibits breast cancer growth by antiangiogenic activity via blocking VEGFR2 signaling.
P2860
Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells.
@en
Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells.
@nl
type
label
Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells.
@en
Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells.
@nl
prefLabel
Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells.
@en
Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells.
@nl
P2093
P2860
P1476
Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells.
@en
P2093
Neil Vasdev
Quan Zhang
Yahui Ding
Yingdai Gao
P2860
P2888
P356
10.1186/S13045-016-0327-5
P577
2016-09-22T00:00:00Z
P6179
1037942905